You just read:

PhRMA: New Analysis Shows Using ICER's Value Assessments Would Limit Access to Life-Saving Medicines in Medicare Part B

News provided by

Pharmaceutical Research and Manufacturers of America (PhRMA)

May 31, 2018, 05:37 ET